title: [A Case of Metastatic Lung Cancer from Colon Cancer with a Long Partial Response with Regorafenib Treatment].
abstract: A 66-year-old woman underwent sigmoidectomy for colon cancer. The final diagnosis was early cancer of pT2 pN0 and M0 (fStage I ). A chest CT revealed lung metastasis and lymph node metastasis 6 years after surgery. The patient was treated sequentially with FOLFOX, FOLFIRI, and XELOX regimens. Since these regimens resulted in progressive disease, regorafenib was started as the fourth regimen. After 8 courses, she was evaluated as having a partial response. Her partial response has continued for 18 months of regorafenib treatment.
authors.affiliation: Dept. of Surgical Oncology, Osaka City University Graduate School of Medicine.
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Iseki
authors.forename: Masakazu
authors.initials: M
authors.lastname: Yashiro
authors.forename: Masatsune
authors.initials: M
authors.lastname: Shibutani
authors.forename: Hisashi
authors.initials: H
authors.lastname: Nagahara
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Maeda
authors.forename: Shinji
authors.initials: S
authors.lastname: Matsutani
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Tamura
authors.forename: Go
authors.initials: G
authors.lastname: Ohira
authors.forename: Sadaaki
authors.initials: S
authors.lastname: Yamazoe
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Kimura
authors.forename: Takahiro
authors.initials: T
authors.lastname: Toyokawa
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Amano
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Tanaka
authors.forename: Kazuya
authors.initials: K
authors.lastname: Muguruma
authors.forename: Kosei
authors.initials: K
authors.lastname: Hirakawa
authors.forename: Masaichi
authors.initials: M
authors.lastname: Ohira
mesh_terms: D000368:Aged; D003082:Colectomy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012811:Sigmoid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013997:Time Factors
chemical_list: D010671:Phenylurea Compounds; D011725:Pyridines; C559147:regorafenib